Norris Medicines has informed that paid up Equity Share Capital of the Company is less than Rs 10 crores and Net worth of the Company is less than Rs 25 crores. Hence, Annual Secretarial compliance Report under Regulation 24A of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 15(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 shall not apply to the Company. The company has enclosed the certificate relating to non-applicability of Regulation 24A of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 issued from Devesh R. Desai, Practicing Company Secretary.
The above information is a part of company’s filings submitted to BSE.
